New stem cell transplant shows promise for kids with tough cancers

NCT ID NCT01625351

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new way to do stem cell transplants in 23 children with cancers that came back or didn't respond to treatment. The method removes certain immune cells from the donor's stem cells to help the child's body recover faster and fight infections better. The goal was to see if the transplant was safe and possible, and to track survival and recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
stem cell transplant with selective T-cell depletion
What this could lead to
If successful, this approach could make stem cell transplants safer and more effective for children with hard-to-treat cancers, potentially improving survival rates.
What could go wrong
This is an early phase I trial with only 23 participants, so results may not apply broadly. Risks include infection, graft failure, and side effects from chemotherapy and immune-suppressing drugs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLEAR CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • St. Jude Children's Research Hospital

    Memphis, Tennessee, 38105, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.